PlainPharmaWatch

CMS Open Payments · Program Year 2024

Janssen Products, LP

Janssen Products, LP reported $473.97 across General Payments, Research, and Ownership to 7 physicians and teaching hospitals across 7 transactions.

See the rankings → How this is sourced
$473.97 Below-median payer
All-tracks total
7 Below-median volume
Transactions
7 Below-median reach
Recipients
−$727.8K
General Payments vs PY2023

Janssen Products, LP reported $473.97 across all CMS Open Payments tracks (General + Research + Ownership) to 7 physicians and teaching hospitals in Program Year 2024 - ranking #1880 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $473.97, averaging $67.71 per recipient.

Janssen Products, LP's payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

13/100

Total payments

F

10/100

Transaction volume

F

10/100

Physician reach

F

10/100

Payment type diversity

F

23/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer janssen-products-lp Janssen Products, LP

$473.97 · #1880/1,925 · 0.0% industry · PY2024

  • TOT $473.97
  • RANK #1880
  • SHARE 0.0%
  • TXN 7
  • RCP 7
  • CAT 2
  • GEN $473.97
  • ΔGEN −$727.8K
  • TOP1 60.1%
  • PY 2024

Volume peers

Nearest volume peer: Align Ophthalmics LLC ($497.15)

Kilele Health Inc$511.98Heraeus Medical Components, …$500.00Nonagen Bioscience Corp$500.00Align Ophthalmics LLC$497.15Janssen Products, LP (this)$473.97
All-tracks payment totals near Janssen Products, LP (CMS Open Payments PY2024)

Janssen Products, LP sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Janssen Products, LP's CMS-reported General Payments decreased by $727.8K (−99.9%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: JANSSEN PRODUCTS, LPPY2023: JANSSEN PRODUCTS, LPPY2024: Janssen Products, LP. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$728.3KPY2024$473.97
PY2023
$728,274.94
PY2024
$473.97

What the Data Shows for Janssen Products, LP

The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Janssen Products, LP that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.

"Travel and Lodging" leads the 2-category general-payment breakdown below at $455.79 (96.2% of General Payments, 5 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Janssen Products, LP made 2 types of general payments. "Travel and Lodging" is the largest category at $455.79, 96.2% of General Payments.

How Janssen Products, LP divides its payments

How the reported total splits across payment categories

1. Travel and Lodging$455.792. Food and Beverage$18.18
Payment Type Amount Transactions
Travel and Lodging $455.79 5
Food and Beverage $18.18 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $473.97 (100.0%) of $473.97 in this company's General Payments records across 2 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Janssen Products, LP

The five named recipients with the highest reported General Payments from this company

Douglas L Cunningham$284.76Paul a Benson$189.21
  1. 1

    Douglas L Cunningham

    $284.76 across 5 reported transactions

  2. 2

    Paul a Benson

    $189.21 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Janssen Products, LP ranks #1880 of 1,925 by total payments (bottom 2% by spend) but is notably more concentrated than that alone would suggest -- #329 of 1,838 by HHI (top 18% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.

02.95.88.711.65176.35196.652175237.45257.7Total payments ($M)Concentration (HHI, 0-10,000)
Janssen Products, LP (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Janssen Products, LP's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Janssen Products, LP.

SPIWay, LLC

HHI 5200

Forthright Medical - MT, LLC

HHI 5198

Solco Biomedical Corporation

HHI 5197

Northgate Technologies, Inc.

HHI 5218

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Janssen Products, LP.

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Janssen Products, LP ranks #1880 of 1,925 by all-tracks total payments, led by "Travel and Lodging".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Janssen Products, LP's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.